(Q57949352)

English

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

scientific article published on 27 February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

0 references

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

Frederic Rolland

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Jaafar Bennouna

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Emmanuelle Bompas

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Eve Marie Neidhardt

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Irène Philip

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Céline Galéa

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Samuel Salot

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Soraya Saiagh

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Marie Audrain

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Marie Rimbert

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sylvie Lafaye-de Micheaux

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Jérôme Tiollier

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sylvie Négrier

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

27 February 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

57

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1599-1609

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

https://scigraph.springernature.com/pub.10.1007/s00262-008-0491-8

0 references

Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0491-8

21 January 2018

In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0491-8

21 January 2018

Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0491-8

21 January 2018

Identifiers

10.1007/S00262-008-0491-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57949352&oldid=2030845544"